FOI release

Approved manufacturing facilities

Case reference FOI2026/00331

Received 25 March 2026

Published 11 June 2026

Request

In switching from originator to generic dapagliflozin, please can you tell me in which country Teva’s dapagliflozin tablets are manufactured as I have concerns over what has been in the press recently in connection with Indian pharmaceutical manufacturers. I understand you cannot disclose the specific site but can you at least tell me the country of manufacture and whether the site is approved. Is the facility approved by the MHRA?

Response

See attached

Documents

• FOI2026_00331 (redacted).pdf (924.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.